Your browser doesn't support javascript.
loading
Alemtuzumab mediates the CD39+ T-regulatory cell response via CD23+ macrophages.
Remez, Lital; Ganelin-Cohen, Esther; Safina, Dina; Hellmann, Mark A; Lotan, Itay; Bosak, Noam; Buxbaum, Chen; Vaknin, Adi; Shifrin, Alla; Rozenberg, Ayal.
Affiliation
  • Remez L; Neuroimmunology Laboratory, Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
  • Ganelin-Cohen E; Neuroimmunological Clinic, Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Safina D; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Hellmann MA; Neuroimmunology Laboratory, Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
  • Lotan I; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bosak N; Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
  • Buxbaum C; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Vaknin A; Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
  • Shifrin A; Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
  • Rozenberg A; Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
Immunol Cell Biol ; 99(5): 521-531, 2021 05.
Article in En | MEDLINE | ID: mdl-33306219

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukocytes, Mononuclear / T-Lymphocytes, Regulatory Limits: Humans Language: En Journal: Immunol Cell Biol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukocytes, Mononuclear / T-Lymphocytes, Regulatory Limits: Humans Language: En Journal: Immunol Cell Biol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: